HF 2196

as introduced - 91st Legislature (2019 - 2020) Posted on 03/07/2019 02:48pm

A bill for an act
relating to health; modifying the task force on medical cannabis therapeutic
research; amending Minnesota Statutes 2018, section 152.36.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2018, section 152.36, is amended to read:

152.36 IMPACT ASSESSMENT OF MEDICAL CANNABIS THERAPEUTIC
RESEARCH.

Subdivision 1.

Task force on medical cannabis therapeutic research.

(a) A deleted text begin 23-member deleted text end
task force on medical cannabis therapeutic research is created to conduct an impact
assessment of medical cannabis therapeutic research. The task force shall consist of the
following members:

(1) two members of the house of representatives, one selected by the speaker of the
house, the other selected by the minority leader;

(2) two members of the senate, one selected by the majority leader, the other selected
by the minority leader;

(3) four members representing new text begin adult new text end consumers or patients enrolled in the registry
program deleted text begin , including at least two parents of patients under age 18 deleted text end ;

new text begin (4) two members who are parents of patients under age 18 enrolled in the registry
program;
new text end

new text begin (5) two members who are caregivers of adult patients enrolled in the registry program;
new text end

deleted text begin (4) deleted text end new text begin (6) new text end four members representing health care providers, including one licensed
pharmacist;

deleted text begin (5) deleted text end new text begin (7) new text end four members representing law enforcement, one from the Minnesota Chiefs of
Police Association, one from the Minnesota Sheriff's Association, one from the Minnesota
Police and Peace Officers Association, and one from the Minnesota County Attorneys
Association;

deleted text begin (6) deleted text end new text begin (8) new text end four members representing substance use disorder treatment providers; and

deleted text begin (7) deleted text end new text begin (9) new text end the commissioners of health, human services, and public safety.

(b) Task force members listed under paragraph (a), clauses (3), (4), (5), deleted text begin and deleted text end (6), new text begin (7), and
(8) new text end shall be appointed by the governor under the appointment process in section 15.0597.
Members shall serve on the task force at the pleasure of the appointing authority. deleted text begin All members
must be appointed by July 15, 2014, and the commissioner of health shall convene the first
meeting of the task force by August 1, 2014.
deleted text end

(c) There shall be two cochairs of the task force chosen from the members listed under
paragraph (a). One cochair shall be selected by the speaker of the house and the other cochair
shall be selected by the majority leader of the senate. The authority to convene meetings
shall alternate between the cochairs.

(d) Members of the task force other than those in paragraph (a), clauses (1), (2), and deleted text begin (7) deleted text end new text begin
(9) new text end , shall receive expenses as provided in section 15.059, subdivision 6.

new text begin (e) The task force shall meet at least once each calendar year.
new text end

Subd. 1a.

Administration.

The commissioner of health shall provide administrative and
technical support to the task force.

Subd. 2.

Impact assessment.

The task force shall hold hearings to evaluate the impact
of the use of medical cannabis and Minnesota's activities involving medical cannabis,
including, but not limited to:

(1) program design and implementation;

(2) the impact on the health care provider community;

(3) patient experiences new text begin and accessibility new text end ;

(4) the impact on the incidence of substance abuse;

(5) access to and quality of medical cannabis and medical cannabis products;

(6) the impact on law enforcement and prosecutions;

(7) public awareness and perception; and

(8) any unintended consequences.

deleted text begin Subd. 3. deleted text end

deleted text begin Cost assessment. deleted text end

deleted text begin By January 15 of each year, beginning January 15, 2015,
and ending January 15, 2019, the commissioners of state departments impacted by the
medical cannabis therapeutic research study shall report to the cochairs of the task force on
the costs incurred by each department on implementing sections 152.22 to 152.37. The
reports must compare actual costs to the estimated costs of implementing these sections and
must be submitted to the task force on medical cannabis therapeutic research.
deleted text end

Subd. 4.

Reports to the legislature.

(a) new text begin Every two years, new text end the cochairs of the task force
shall submit deleted text begin the following reports deleted text end to the chairs and ranking minority members of the
legislative committees and divisions with jurisdiction over health and human services, public
safety, judiciary, and civil law deleted text begin :
deleted text end

deleted text begin (1) by February 1, 2015, a report on the design and implementation of the registry
program; and every two years deleted text end deleted text begin thereafter, deleted text end a complete impact assessment report deleted text begin ; and deleted text end new text begin on the
ability of patients to access medical cannabis and on the affordability of medical cannabis.
new text end

deleted text begin (2) upon receipt of a cost assessment from a commissioner of a state agency, the
completed cost assessment.
deleted text end

(b) The task force may make recommendations to the legislature on whether to add or
remove conditions from the list of qualifying medical conditions.

new text begin (c) The task force shall, on an ongoing basis, assess problems in the medical cannabis
program and challenges faced by patients in accessing and affording medical cannabis, and
shall report any problems identified and recommendations to address those problems to the
chairs and ranking minority members of the legislative committees and divisions with
jurisdiction over health and human services, public safety, judiciary, and civil law, by July
1 each year.
new text end

Subd. 5.

No expiration.

The task force on medical cannabis therapeutic research does
not expire.